TY - CHAP M1 - Book, Section TI - Chapter 35B. Perspective on Inflammatory Bowel Disease (Ulcerative Colitis and Crohn's Disease) A1 - Roberts, Patricia L. A2 - Zinner, Michael J. A2 - Ashley, Stanley W. Y1 - 2013 N1 - T2 - Maingot's Abdominal Operations, 12e AB - Ulcerative colitis and Crohn's disease, collectively known as inflammatory bowel disease (IBD), are estimated to affect 2–6% of the population of the United States. Despite advances in medical therapy and a larger number of effective medications for treatment of this disease, up to 46% of patients with ulcerative colitis and 80% of patients with Crohn's disease ultimately require surgery.1,2 While many of the operative procedures have remained the same, the approach has changed with the advent of minimally invasive surgery. Laparoscopic colorectal surgery, initially reported in the 1990s, has increased in frequency and is associated with a faster recovery, potentially less complications, better cosmesis, and a shorter length of stay. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/03/29 UR - accesssurgery.mhmedical.com/content.aspx?aid=57021300 ER -